P101 Anti-CD19 CAR-T cell therapy for refractory childhood-onset systemic lupus erythematosus

• Franco Locatelli,
• Claudia Bracaglia,
• Pietro Merli,
• Mattia Algeri,
• Rebecca Nicolai,
• Fabrizio de Benedetti,
• Emiliano Marasco,
• Patricia Moran Alvarez,
• Maria Giuseppina Cefalo,
• Marco Becilli

Affiliations

Franco Locatelli

8 Department of Pediatric Hematology and Oncology, Bambino Gesu Pediatric Hospital, Roma, Italy

Claudia Bracaglia

1Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy

Pietro Merli

Department Onco-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy

Mattia Algeri

Department Onco-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy

Rebecca Nicolai

Division of Rheumatology, Bambino Gesù Children`s Hospital, IRCCS, Rome, Italy

Fabrizio de Benedetti

1Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Roma, Italy

Emiliano Marasco

Division of Rheumatology, Bambino Gesù Children`s Hospital, IRCCS, Rome, Italy

Patricia Moran Alvarez

1Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Roma, Italy

Maria Giuseppina Cefalo

2Dept. of Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children’s Hospital, Rome, Italy

Marco Becilli

2Dept. of Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children’s Hospital, Rome, Italy